Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C to Reduce Vasopressor Dose in Septic Shock
NCT03835286Phase 3Withdrawn
- Sponsor
- Hospital Español de México
- Start
- Mar 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid in septic shock, sponsored by Hospital Español de México. Planned start Mar 2019; status: withdrawn.
02
Drugs
ascorbic acid
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03835286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03835286.